Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) price closed lower on Friday, June 27, and dropping -11.66% below its previous close.
A look at the daily price movement shows that the last close reads $0.93, with intraday deals fluctuated between $0.8209 and $0.9498. The company’s 5Y monthly beta was ticking 1.008. Taking into account the 52-week price action we note that the stock hit a 52-week high of $2.45 and 52-week low of $0.28. The stock added 17.37% on its value in the past month.
Lexicon Pharmaceuticals Inc, which has a market valuation of $298.13 million, is expected to release its quarterly earnings report on 2025-May-13.
The average estimate suggests sales growth for the quarter will likely rise by 195.54% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of 13.83M for the company’s annual revenue in current year. Per this projection, the revenue is forecast to grow -55.50% below that which the company brought in the current year earning report.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give LXRX a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as Hold.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 3 analysts have assigned LXRX a recommendation rating as follows: 0 rate it as a Hold; 3 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Lexicon Pharmaceuticals Inc (LXRX) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that LXRX’s price is at present 12.61% off the SMA20 and 21.30% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 59.62, with weekly volatility standing at 11.30%. The indicator jumps to 9.37% when calculated based on the past 30 days. Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s beta value is holding at 1.10. Considering analysts have assigned the stock a price target range of $6-$6 as the low and high respectively, we find the trailing 12-month average consensus price target to be $6. Based on this estimate, we see that current price is roughly -631.71% off the estimated low and -631.71% off the forecast high. Investors will no doubt be excited to see the share price fall to $6, which is the median consensus price, and at that level LXRX would be -631.71% from current price.
An analysis of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock in terms of its daily trading volume indicates that the 3-month average is 13.55 million. However, this figure increases on the past 10-day timeline to an average of 6.0 million.
Current records show that the company has 363.18M in outstanding shares. The insiders’ percentage holdings are 51.26% of outstanding shares while the percentage share held by institutions stands at 26.54%. The stats also highlight that short interest as of 2025-06-13, stood at 37.56 million shares, which puts the short ratio at the time at 9.39. From this we can glean that short interest is 2891.00 of company’s current outstanding shares. Notably, we see that shares short in June fall slightly given the previous month’s figure stood at 43.03 million. But the -54.65% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
